Table 1. Clinical characteristics of patients with retinal vascular diseases.
| Age | Gender | Disease type | Eye | VA (Snellen) | HbA1c (%) | Duration of DM (year) | |
|---|---|---|---|---|---|---|---|
| Case1 | 41 | M | DR | R | 20/20 | 7.4 | 3 |
| Case2 | 59 | M | DR | R | 20/20 | — | 6.5 |
| Case3 | 64 | F | DR | L | 20/125 | 6 | 15 |
| Case4 | 65 | M | DR | R L | 20/12.5 20/20 | 8 | 6 |
| Case5 | 61 | F | DR | R L | 20/20 20/16 | 6.4 | 12 |
| Case6 | 52 | F | DR | R | 20/20 | 8.2 | 3 |
| Case7 | 76 | F | DR | L | 20/200 | — | 17 |
| Case8 | 22 | F | DR | L | 20/12.5 | 8.7 | 19 |
| Case9 | 59 | F | DR | L | 20/40 | 7.2 | 6 |
| Case10 | 62 | M | DR | R | 20/20 | 6 | 4 |
| Case11 | 42 | M | DR | R | 20/16 | 10 | 12 |
| Case12 | 65 | M | DR | L | 20/20 | 13.1 | 10 |
| Case13 | 47 | M | DR | R | 20/12.5 | 7 | 12 |
| Case14 | 66 | F | DR | R | 20/16 | 14 | 10 |
| Case15 | 58 | M | DR | R | 20/25 | 7.1 | 7 |
| Case16 | 67 | F | DR | R | 20/20 | 6.1 | 10 |
| Case17 | 54 | M | DR | R | 20/63 | 6.5 | 12 |
| Case18 | 70 | M | DR | L | 20/20 | 10.5 | 15 |
| Case19 | 79 | M | DR | L | 20/160 | — | — |
| Case20 | 76 | F | DR | R | 20/160 | — | — |
| Case21 | 63 | M | DR | R L | 20/20 20/20 | 7.5 | 20 |
| Case22 | 51 | F | DR | R | 20/32 | 9.3 | 10 |
| Case23 | 84 | F | BRVO | L | 20/200 | — | — |
| Case24 | 55 | F | BRVO | L | 20/20 | — | — |
| Case25 | 74 | F | BRVO | L | 20/16 | — | — |
| Case26 | 62 | F | BRVO | R | 20/40 | — | — |
| Case27 | 75 | M | BRVO | L | 20/25 | — | — |
| Case28 | 37 | M | Hypertensive retinopathy | L | 20/20 | — | — |
| Case29 | 22 | F | Renal retinopathy | R | 20/63 | — | — |